These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20082475)

  • 1. Heparanase and hepatocellular carcinoma: promoter or inhibitor?
    Dong S; Wu XZ
    World J Gastroenterol; 2010 Jan; 16(3):306-11. PubMed ID: 20082475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase-1: From Cancer Biology to a Future Antiviral Target.
    Lebsir N; Zoulim F; Grigorov B
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme.
    Tayel A; Abd El Galil KH; Ebrahim MA; Ibrahim AS; El-Gayar AM; Al-Gayyar MM
    Eur J Pharmacol; 2014 Apr; 728():151-60. PubMed ID: 24530413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
    Lanzi C; Zaffaroni N; Cassinelli G
    Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans.
    Levy-Adam F; Feld S; Suss-Toby E; Vlodavsky I; Ilan N
    PLoS One; 2008 Jun; 3(6):e2319. PubMed ID: 18545691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.
    El-Assal ON; Yamanoi A; Ono T; Kohno H; Nagasue N
    Clin Cancer Res; 2001 May; 7(5):1299-305. PubMed ID: 11350898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma.
    Zhang Y; Li L; Wang Y; Zhang J; Wei G; Sun Y; Shen F
    Biochem Biophys Res Commun; 2007 Jun; 358(1):124-9. PubMed ID: 17467664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
    Marchetti D; Liu S; Spohn WC; Carson DD
    J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
    Ilan N; Elkin M; Vlodavsky I
    Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
    Vlodavsky I; Goldshmidt O; Zcharia E; Atzmon R; Rangini-Guatta Z; Elkin M; Peretz T; Friedmann Y
    Semin Cancer Biol; 2002 Apr; 12(2):121-9. PubMed ID: 12027584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian heparanase: what is the message?
    Vreys V; David G
    J Cell Mol Med; 2007; 11(3):427-52. PubMed ID: 17635638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.
    Lanzi C; Cassinelli G
    Biochem Pharmacol; 2020 Aug; 178():114084. PubMed ID: 32526230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase: Historical Aspects and Future Perspectives.
    Khanna M; Parish CR
    Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas.
    Cassinelli G; Zaffaroni N; Lanzi C
    Cancer Lett; 2016 Nov; 382(2):245-254. PubMed ID: 27666777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase: Potential roles in multiple sclerosis.
    Changyaleket B; Deliu Z; Chignalia AZ; Feinstein DL
    J Neuroimmunol; 2017 Sep; 310():72-81. PubMed ID: 28778449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Heparanase Regulatory Network in Health and Disease.
    Mayfosh AJ; Nguyen TK; Hulett MD
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular properties and involvement of heparanase in cancer progression and normal development.
    Vlodavsky I; Goldshmidt O; Zcharia E; Metzger S; Chajek-Shaul T; Atzmon R; Guatta-Rangini Z; Friedmann Y
    Biochimie; 2001 Aug; 83(8):831-9. PubMed ID: 11530216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
    Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
    Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Heparan Sulfate and Heparanase in Amyloid Diseases.
    Li JP; Zhang X
    Adv Exp Med Biol; 2020; 1221():631-645. PubMed ID: 32274729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase: one molecule with multiple functions in cancer progression.
    Vlodavsky I; Elkin M; Abboud-Jarrous G; Levi-Adam F; Fuks L; Shafat I; Ilan N
    Connect Tissue Res; 2008; 49(3):207-10. PubMed ID: 18661344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.